Management of a patient on dual antiplatelet therapy presented for living donor liver transplant  

作　　者：Marina Moguilevitch Ellise Delphin James Widyn David Turk 

机构地区：[1]Department of Anesthesiology, Montefiore Medical Center, Bronx, USA

出　　处：《Case Reports in Clinical Medicine》2013年第2期115-118,共4页临床医学病理报告（英文）

摘　　要：We report a case of a patient who underwent Living Donor Liver Transplantation (LDLT) while being continued on his dual antiplatelet regimen of clopidigrel and aspirin perioperatively. The patient had two drug eluting stents for coronary artery disease placed eight months prior to surgery. Preoperative thromboelastography and platelet mapping showed normal clot formation. Based on these tests it was determined that preoperative platelet transfusion was not necessary. The surgery proceeded relatively uneventfully. The patient received 1 unit of packed red blood cells intraoperatively and continued on aspirin during the postoperative period with no evidence of bleeding or cardiac ischemia.We report a case of a patient who underwent Living Donor Liver Transplantation (LDLT) while being continued on his dual antiplatelet regimen of clopidigrel and aspirin perioperatively. The patient had two drug eluting stents for coronary artery disease placed eight months prior to surgery. Preoperative thromboelastography and platelet mapping showed normal clot formation. Based on these tests it was determined that preoperative platelet transfusion was not necessary. The surgery proceeded relatively uneventfully. The patient received 1 unit of packed red blood cells intraoperatively and continued on aspirin during the postoperative period with no evidence of bleeding or cardiac ischemia.

关 键 词：Liver TRANSPLANTATION ANTIPLATELET Drugs Blood TRANSFUSION CORONARY ARTERY Disease 

分 类 号：R73[医药卫生—肿瘤]